Position in AZN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$8,584,476
New position
Shares Held
45,272
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#321
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oliver Luxxe Assets LLC holds $24,335,082 across 7 Drug Manufacturers - General names. AZN ranks #1 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
45,272 | $8,584,476 | |
| 2 | ABBV |
AbbVie Inc.
|
31,485 | $7,922,885 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
52,852 | $6,677,321 | |
| 4 | PFE |
Pfizer Inc
|
18,762 | $451,788 | |
| 5 | JNJ |
Johnson & Johnson
|
1,059 | $268,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 | |
| 7 | AMGN |
Amgen Inc
|
590 | $213,650 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,584,476 | 45,272 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||